Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2

Am J Gastroenterol. 2020 Aug;115(8):1283-1285. doi: 10.14309/ajg.0000000000000719.

Abstract

Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anastomosis, Roux-en-Y
  • Anemia / etiology
  • Anemia / therapy*
  • Betacoronavirus
  • COVID-19
  • Conservative Treatment
  • Coronavirus Infections / complications
  • Coronavirus Infections / therapy*
  • Erythrocyte Transfusion
  • Female
  • Gastrointestinal Hemorrhage / complications
  • Gastrointestinal Hemorrhage / therapy*
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Peptic Ulcer Hemorrhage / complications
  • Peptic Ulcer Hemorrhage / therapy
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / therapy*
  • Postoperative Complications / therapy
  • Proton Pump Inhibitors / therapeutic use
  • SARS-CoV-2
  • Severity of Illness Index
  • Ulcer / complications
  • Ulcer / therapy

Substances

  • Proton Pump Inhibitors